NutriBand (NTRB) Receivables (2018 - 2026)
NutriBand (NTRB) posted Receivables of $102632.0 for Q2 2026, down 53.01% sequentially from $218404.0 in Q1 2026, and up 9.03% YoY from $94136.0 in Q2 2025.
NutriBand (NTRB) Receivables (2018 - 2026) Analysis & Trends
NutriBand has reported Receivables for 9 years, with the latest figure at $102632.0 in Q2 2026.
- Quarterly Receivables rose 9.03% year-over-year to $102632.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $102632.0 (up 9.03% YoY) and the FY2026 annual result came in at $218404.0, up 105.02% from the prior year.
- Receivables fell to $102632.0 in Q2 2026 per NTRB's latest filing, from $218404.0 in the prior quarter.
- Over five years, Receivables peaked at $260804.0 in Q3 2025 and troughed at $71380.0 in Q1 2022.
- A 5-year average of $157612.1 and a median of $155599.0 in 2022 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2025: Receivables surged 964.71% in 2022, then tumbled 70.3% in 2025.
- Over 5 years, Receivables stood at $80455.0 in 2022, then surged by 110.89% to $169669.0 in 2023, then grew by 23.55% to $209630.0 in 2024, then grew by 18.09% to $247562.0 in 2025, then slumped by 58.54% to $102632.0 in 2026.
- According to Business Quant data, Receivables over the past three periods registered $102632.0, $218404.0, and $247562.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 102,632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 102,632.00 |
| Jan 31, 2026 | 218,404.00 |
| Oct 31, 2025 | 247,562.00 |
| Jul 31, 2025 | 260,804.00 |
| Apr 30, 2025 | 94,136.00 |
| Jan 31, 2025 | 73,847.00 |
| Oct 31, 2024 | 209,630.00 |
| Jul 31, 2024 | 106,528.00 |
| Apr 30, 2024 | 206,528.00 |
| Jan 31, 2024 | 248,649.00 |
| Oct 31, 2023 | 169,669.00 |
| Jul 31, 2023 | 223,452.00 |
| Apr 30, 2023 | 164,641.00 |
| Jan 31, 2023 | 113,045.00 |
| Oct 31, 2022 | 80,455.00 |
| Jul 31, 2022 | 146,557.00 |
| Apr 30, 2022 | 99,098.00 |
| Jan 31, 2022 | 71,380.00 |
| Oct 31, 2021 | 146,411.00 |
| Jul 31, 2021 | 13,765.00 |